Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Ohana Biosciences
Headquarters: Cambridge, MA, United States of America
Website: https://www.ohanabio.com
Year Founded: 2016
Status: Archived
BioCentury | Sep 25, 2023
Management Tracks
Remy Sukhija leaving Madrigal as CCO
Plus: Editas hires Caren Deardorf as chief commercial and strategy officer, and updates from ProFound and hC
BioCentury | Jul 13, 2022
Emerging Company Profile
Epic Bio: Epigenome editing via compact components
Horizons Ventures leads $55M series A for start-up developing compact epigenome editors with all-in-one AAV delivery
BioCentury | Feb 11, 2022
Management Tracks
Silberstein joins GentiBio as CFO
Plus new CTO, CDO at Finch; and updates from Generation Bio, Atea and more
BioCentury | Jul 8, 2021
Management Tracks
Chin returns to Arix to rebuild investment team as three more depart; plus ADCendo, Magenta, Junshi, Valneva, Q32 Bio, Outlook, Quotient Catalyst, Kaleido, Amolyt and more
Mark Chin is rejoining Arix Bioscience plc (LSE:ARIX) as managing director with a mandate to rebuild the VC’s investment team. Managing Director Christian Schetter, Principal John Cassidy
BioCentury | May 1, 2021
Regulation
April 30 Quick Takes: Bilenker has $212M to build newco Treeline’s toolbox; plus Farxiga, Opdivo, BioCryst, Leo, Hikma and more
An SEC filing released Friday revealed that Josh Bilenker and Jeffrey Engelman have $212 million to begin building newly launched Treeline Biosciences Inc.’s toolbox for chasing validated but
BioCentury | Oct 24, 2020
Translation in Brief
UNC Chapel Hill Angelman gene therapy rescues motor function; plus data backing planned Pacylex, Kronos clinical trials and more
BioCentury’s roundup of translational news
BioCentury | Apr 18, 2020
Management Tracks
PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more
BioCentury | Apr 2, 2020
Finance
Billion-dollar funds from Arch, Flagship show VCs are open for business
War chests show interest in biotech hasn’t waned amid pandemic
BioCentury | Feb 15, 2020
Management Tracks
Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more
BioCentury | Jan 27, 2020
Emerging Company Profile
Ohana: Looking to the other half of reproductive biology
Ohana is applying single cell sequencing to the unexplored male half of reproductive biology
Items per page:
1 - 10 of 11